Search Results - Vittore Cereda
- Showing 1 - 7 results of 7
-
1
Human dendritic cell maturation and activation by a heat-killed recombinant yeast (Saccharomyces cerevisiae) vector encoding carcinoembryonic antigen by Cinzia Remondo, Vittore Cereda, Sven Mostböck, Helen Sabzevari, Alex Franzusoff, Jeffrey Schlom, Kwong-Y. Tsang
Published 2008Artigo -
2
Venous thromboembolism risk prediction in ambulatory cancer patients: Clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio by Patrizia Ferroni, Silvia Riondino, Vincenzo Formica, Vittore Cereda, Livia Tosetto, Francesca Farina, Maria Giovanna Valente, Matteo Vergati, Fiorella Guadagni, Mario Roselli
Published 2014Artigo -
3
Effects of conventional therapeutic interventions on the number and function of regulatory T cells by Mario Roselli, Vittore Cereda, Maria Giovanna di Bari, Vincenzo Formica, Antonella Spila, Caroline Jochéms, Benedetto Farsaci, Renee N. Donahue, James L. Gulley, Jeffrey Schlom, Fiorella Guadagni
Published 2013Artigo -
4
Safety and Immunologic Response of a Viral Vaccine to Prostate-Specific Antigen in Combination with Radiation Therapy when Metronomic-Dose Interleukin 2 Is Used as an Adjuvant by Robert J. Lechleider, Philip M. Arlen, Kwong-Yok Tsang, Seth M. Steinberg, Junko Yokokawa, Vittore Cereda, Kevin Camphausen, Jeffrey Schlom, William L. Dahut, James L. Gulley
Published 2008Artigo -
5
Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccination by Matteo Vergati, Vittore Cereda, Ravi A. Madan, James L. Gulley, N. Y. Macy Huen, Connie J. Rogers, Kenneth W. Hance, Philip M. Arlen, Jeffrey Schlom, Kwong Y. Tsang
Published 2010Artigo -
6
Pilot Study of Vaccination with Recombinant CEA-MUC-1-TRICOM Poxviral-Based Vaccines in Patients with Metastatic Carcinoma by James L. Gulley, Philip M. Arlen, Kwong-Yok Tsang, Junko Yokokawa, Claudia Palena, Diane J. Poole, Cinzia Remondo, Vittore Cereda, Jacquin Jones, Mary Pazdur, Jack P. Higgins, James W. Hodge, Seth M. Steinberg, Herbert L. Kotz, William L. Dahut, Jeffrey Schlom
Published 2008Artigo -
7
Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer by James L. Gulley, Philip M. Arlen, Ravi A. Madan, Kwong-Yok Tsang, Mary Pazdur, Lisa Skarupa, Jacquin Jones, Diane J. Poole, Jack P. Higgins, James W. Hodge, Vittore Cereda, Matteo Vergati, Seth M. Steinberg, Susan Halabi, Elizabeth C. Jones, Clara Chen, Howard L. Parnes, James R. Wright, William L. Dahut, Jeffrey Schlom
Published 2009Artigo
Search Tools:
Related Subjects
Cancer
Immunology
Internal medicine
Medicine
Oncology
Immune system
Immunotherapy
Prostate cancer
Antigen
Biochemistry
Biology
Vaccination
Chemotherapy
FOXP3
Gastroenterology
In vitro
Nomogram
T cell
Adjuvant
Ambulatory
Antigen presentation
Antigen-presenting cell
Breast cancer
CD40
CD80
Cancer immunotherapy
Carcinoembryonic antigen
Carcinoma
Chemotherapy regimen
Cisplatin